title: Prevention of metabolic syndrome in serious mental illness.
abstract: The interaction of lifestyle, socioeconomic status, genetic factors, and treatment with antipsychotic medications likely accounts for the high risk of metabolic syndrome, diabetes, heart disease, and premature mortality in people with serious mental illness. Given the high risk of developing diabetes and cardiovascular disease in persons with serious mental illness, psychiatrists who treat these individuals need to ensure they are familiar with these risks, monitor metabolic parameters in their patients, and educate their patients (and caregivers) about the risks and how to prevent them.
authors.affiliation: Center for Addiction and Mental Health, University of Toronto, 901 King Street West, Toronto, Ontario, Canada. Rohan_Ganguli@camh.net
authors.forename: Rohan
authors.initials: R
authors.lastname: Ganguli
authors.forename: Martin
authors.initials: M
authors.lastname: Strassnig
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects; D006801:Humans; D001523:Mental Disorders / Q000150:complications*; D024821:Metabolic Syndrome / Q000139:chemically induced / Q000150:complications / Q000517:prevention & control*; D009765:Obesity / Q000517:prevention & control; D011314:Preventive Health Services / Q000379:methods; D011322:Primary Prevention / Q000379:methods*
chemical_list: D014150:Antipsychotic Agents